Health Catalyst, Inc.
HCAT
$3.80
-$0.185-4.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.33% | 31.80% | 33.16% | 58.56% | 37.97% |
| Total Depreciation and Amortization | 15.94% | -5.34% | -7.50% | -3.22% | -7.61% |
| Total Amortization of Deferred Charges | 47.82% | 48.37% | 54.12% | 8.20% | 7.84% |
| Total Other Non-Cash Items | -44.32% | -26.74% | -41.54% | -41.09% | 0.51% |
| Change in Net Operating Assets | -55.13% | 71.42% | 7.57% | 12.58% | 178.72% |
| Cash from Operations | -97.27% | 81.48% | 99.29% | 113.93% | 283.98% |
| Capital Expenditure | -222.12% | -61.96% | -373.15% | 28.75% | 51.06% |
| Sale of Property, Plant, and Equipment | 133.33% | -70.00% | -70.00% | -20.00% | -50.00% |
| Cash Acquisitions | -- | -122.86% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 64.57% | -309.25% | 280.34% | 344.72% | 264.96% |
| Cash from Investing | 15.21% | -476.87% | 130.76% | 75.95% | 270.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -19.47% | -11.39% | -35.67% | -41.93% | -54.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -646.00% | 9,441.77% | 10,716.83% | -41.93% | 827.96% |
| Foreign Exchange rate Adjustments | 63.16% | -382.35% | 653.33% | 33.33% | -480.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.91% | -795.99% | 710.25% | 102.95% | 453.93% |